Sign in

CIK 0001422142

  • Non-accelerated filer
  • Smaller reporting company

Whitehawk Therapeutics, Inc.

Sign in to watch
Ticker
WHWK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547850
Phone
+1 551-321-2234
Business address
2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
Former names
Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 22 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-09-26 Giacobello Scott M. Chief Financial Officer Grant or award +20,000 $12.50 $250K 20,000
2022-09-22 Aghazadeh Behzad Director Grant or award +1,260,000 $12.50 $15.8M 3,471,752
2022-06-15 Reeve Emma Director Grant or award · Stock Option (right to buy) +18,573 18,573
2022-06-15 Maroun Richard E Director Grant or award · Stock Option (right to buy) +18,573 18,573
2022-06-15 Hehenberger Karin M. Director Grant or award · Stock Option (right to buy) +18,573 18,573
2022-06-15 Dalal Anupam Director Grant or award · Stock Option (right to buy) +18,573 18,573
2022-06-15 Castelein Caley Director Grant or award · Stock Option (right to buy) +18,573 18,573
2022-06-15 Aghazadeh Behzad Director Grant or award · Stock Option (right to buy) +18,573 18,573
2022-04-01 Delaney Brendan Chief Operating Officer Grant or award · Stock option (right to buy) +61,000 61,000
2022-04-01 ITRI LORETTTA M Chief Medical Officer Grant or award · Stock option (right to buy) +67,300 67,300
2022-04-01 Giacobello Scott M. Chief Financial Officer Grant or award · Stock option (right to buy) +46,400 46,400
2022-04-01 Desai Neil See Remarks Grant or award · Stock option (right to buy) +153,300 153,300
2022-03-18 Desai Neil See Remarks Sale −3,550 $20.07 $71K 1,915,543
2021-10-21 ITRI LORETTTA M Chief Medical Officer Grant or award · Stock option (right to buy) +185,000 185,000
2021-09-20 Delaney Brendan Chief Operating Officer Grant or award · Stock option (right to buy) +260,000 260,000
2021-09-08 Desai Neil See Remarks Grant or award · Stock option (right to buy) +125,000 125,000
2021-09-08 Reeve Emma Director Grant or award · Stock option (right to buy) +16,486 16,486
2021-08-27 Hehenberger Karin M. Director Grant or award · Stock option (right to buy) +17,549 17,549
2021-08-27 Maroun Richard E Director Grant or award · Stock option (right to buy) +17,549 17,549
2021-08-27 Aghazadeh Behzad Director Grant or award · Stock option (right to buy) +17,549 17,549

Page 10 of 16 · 312 trades